DK0789710T3 - Peptider til anti-allergisk behandling - Google Patents

Peptider til anti-allergisk behandling

Info

Publication number
DK0789710T3
DK0789710T3 DK95936020T DK95936020T DK0789710T3 DK 0789710 T3 DK0789710 T3 DK 0789710T3 DK 95936020 T DK95936020 T DK 95936020T DK 95936020 T DK95936020 T DK 95936020T DK 0789710 T3 DK0789710 T3 DK 0789710T3
Authority
DK
Denmark
Prior art keywords
pct
peptides
date
terminus
sec
Prior art date
Application number
DK95936020T
Other languages
Danish (da)
English (en)
Inventor
Denis Raymond Stanworth
Ian Victor Lewin
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Application granted granted Critical
Publication of DK0789710T3 publication Critical patent/DK0789710T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95936020T 1994-11-04 1995-11-03 Peptider til anti-allergisk behandling DK0789710T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422294A GB9422294D0 (en) 1994-11-04 1994-11-04 Peptides for anti-allergy treatment
PCT/GB1995/002580 WO1996014333A1 (en) 1994-11-04 1995-11-03 Peptides for anti-allergy treatment

Publications (1)

Publication Number Publication Date
DK0789710T3 true DK0789710T3 (da) 1999-11-01

Family

ID=10763914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95936020T DK0789710T3 (da) 1994-11-04 1995-11-03 Peptider til anti-allergisk behandling

Country Status (12)

Country Link
US (1) US5945104A (de)
EP (1) EP0789710B1 (de)
JP (1) JPH10509700A (de)
AT (1) ATE179989T1 (de)
AU (1) AU707483B2 (de)
CA (1) CA2204256A1 (de)
DE (1) DE69509673T2 (de)
DK (1) DK0789710T3 (de)
ES (1) ES2131339T3 (de)
GB (1) GB9422294D0 (de)
GR (1) GR3030777T3 (de)
WO (1) WO1996014333A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822763D0 (en) * 1998-10-20 1998-12-16 Univ Sheffield Immunoglobin variant
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000252B1 (de) * 1977-06-29 1982-02-03 Beecham Group Plc Peptiden, Verfahren zu dessen Herstellung und denen enthaltende pharmazeutische Präparate
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
EP0378881B1 (de) * 1989-01-17 1993-06-09 ENIRICERCHE S.p.A. Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JP3329868B2 (ja) * 1992-09-30 2002-09-30 株式会社クラレ ペプチドおよびこれを担体上に固定化してなる吸着剤
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
WO1994018345A1 (en) * 1993-02-05 1994-08-18 Affymax Technologies N.V. Receptor-binding antiproliferative peptides
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
JP3504963B2 (ja) * 1993-10-22 2004-03-08 智靖 羅 抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片

Also Published As

Publication number Publication date
WO1996014333A1 (en) 1996-05-17
DE69509673D1 (de) 1999-06-17
AU3811195A (en) 1996-05-31
AU707483B2 (en) 1999-07-08
JPH10509700A (ja) 1998-09-22
GR3030777T3 (en) 1999-11-30
US5945104A (en) 1999-08-31
CA2204256A1 (en) 1996-05-17
DE69509673T2 (de) 2000-01-13
ATE179989T1 (de) 1999-05-15
GB9422294D0 (en) 1994-12-21
ES2131339T3 (es) 1999-07-16
EP0789710B1 (de) 1999-05-12
EP0789710A1 (de) 1997-08-20

Similar Documents

Publication Publication Date Title
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
CA2180950A1 (en) Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
DE69736634D1 (de) Antagonisten des intestinotrophen glp-2 peptides
DK0770089T3 (da) Vækstdifferentieringsfaktor-12
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
BG102362A (en) New derivatives of amino acids, their preparation and application
ATE290315T1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
ATE374618T1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
NO952385L (no) Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen
IL128569A0 (en) Fibroblast growth factor homologous factor S(FHFs) and methods of use
DK0789710T3 (da) Peptider til anti-allergisk behandling
NO975565L (no) Benstimulerende faktor
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
MY109158A (en) Modified platelet factor-4.
DE69526972T2 (de) Verwendung von Gabapentin in der Behandlung vonAngst - und Panikstörungen
BG105682A (en) Bone stimulating factor
NO961995L (no) Anvendelse av IGF-BP for renaturering av IGF
WO1997039020A3 (en) Antigenic sequences of a sperm protein and immunocontraceptive methods
UA32668A (uk) Спосіб лікування полінозів у дітей
MX9707501A (es) Dominio intracelular de la proteina her-2/neu para la prevencion o tratamiento de malignidades.